Identification of a novel prognostic model for gastric cancer utilizing glutamine-related genes
The present study has generated a novel risk module containing four DE-GMRGs for predicting the prognosis and the response to immune checkpoint blockade treatments for GC. This risk model provides new insights into the involvement of glutamine metabolism in GC, warranting further investigation.
Authors
- Weidong Li (ORCID: https://orcid.org/0000-0001-5924-7989)
- Jun Ouyang (ORCID: https://orcid.org/0000-0003-2481-7907)
- Haitao Wang (ORCID: https://orcid.org/0009-0004-3423-7652)
- Xinhao Zhou (ORCID: https://orcid.org/0000-0003-2003-5967)
- Kai Li (ORCID: https://orcid.org/0000-0001-6544-6052)
- Xueying Sun (ORCID: https://orcid.org/0000-0002-8065-8747)
- Yao Wang (ORCID: https://orcid.org/0000-0002-3305-8933)
- Naisheng Deng
- Zhifen Guan
- Qixing Zhong
Institutions
- University of Auckland (NZ)
- Zhongshan People's Hospital (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e37985
- Citations
- 2
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Guangdong Provincial Applied Science and Technology Research and Development Program
- High-level Hospital Construction Project of Guangdong Provincial People's Hospital